Indivior (INDV) RNS Announcements

Add to Alert list
Date Time Source Announcement
14 Feb 2017 04:19 PM
RNS
Holding(s) in Company
13 Feb 2017 07:00 AM
RNS
Holding(s) in Company
10 Feb 2017 04:48 PM
RNS
Holding(s) in Company
09 Feb 2017 09:56 AM
RNS
Holding(s) in Company
06 Feb 2017 12:00 PM
RNS
Notice of Results
03 Feb 2017 01:30 PM
RNS
Director Declaration
01 Feb 2017 07:00 AM
RNS
Total Voting Rights
24 Jan 2017 01:00 PM
RNS
Directorate Change
09 Jan 2017 01:00 PM
RNS
JP Morgan Healthcare Conference
23 Dec 2016 09:21 AM
RNS
Holding(s) in Company
09 Dec 2016 12:55 PM
RNS
Research & Development Day in New York
28 Nov 2016 01:53 PM
RNS
Additional Listing
10 Nov 2016 03:54 PM
RNS
Block Listing Six Monthly Return
02 Nov 2016 12:00 PM
RNS
3rd Quarter Results
27 Oct 2016 04:53 PM
RNS
Notice of Results
03 Oct 2016 02:00 PM
RNS
Directorate Change
03 Oct 2016 09:17 AM
RNS
Holding(s) in Company
27 Sep 2016 07:00 AM
RNS
State Attorneys General Complaint Filed
23 Sep 2016 07:00 AM
RNS
Civil Complaint Filed by State Attorneys General
01 Sep 2016 02:22 PM
RNS
Appointment Update
17 Aug 2016 07:00 AM
RNS
Top-line Phase 3 Pivotal Study Results - RBP-6000
16 Aug 2016 02:19 PM
RNS
Director Declaration
12 Aug 2016 10:45 AM
RNS
Director/PDMR Shareholding
03 Aug 2016 10:05 AM
RNS
Director/PDMR Shareholding
02 Aug 2016 03:05 PM
RNS
Director/PDMR Shareholding
29 Jul 2016 07:00 AM
RNS
Half Year Financial Results
15 Jul 2016 07:00 AM
RNS
Intention to List ADRs in U.S.
12 Jul 2016 02:00 PM
RNS
Notice of Results
08 Jul 2016 04:30 PM
RNS
Dividend Conversion Rate
28 Jun 2016 04:32 PM
RNS
Director/PDMR Shareholding
16 Jun 2016 10:23 AM
RNS
Holding(s) in Company
08 Jun 2016 05:10 PM
RNS
Holding(s) in Company
06 Jun 2016 12:19 PM
RNS
Holding(s) in Company
03 Jun 2016 04:23 PM
RNS
Indivior welcomes Court ruling in ANDA litigation
01 Jun 2016 09:50 AM
RNS
Total Voting Rights
26 May 2016 05:33 PM
RNS
Buprenorphine Monthly Depot - FDA Fast Track
24 May 2016 03:45 PM
RNS
Director/PDMR Shareholding
16 May 2016 03:00 PM
RNS
Director/PDMR Shareholding
16 May 2016 01:45 PM
RNS
Director/PDMR Shareholding
13 May 2016 01:31 PM
RNS
Director/PDMR Shareholding
12 May 2016 04:13 PM
RNS
Director/PDMR Shareholding
11 May 2016 05:50 PM
RNS
Result of AGM
04 May 2016 03:16 PM
RNS
Additional Listing
03 May 2016 12:00 PM
RNS
1st Quarter Results
28 Apr 2016 02:25 PM
RNS
Result of Phase 1 trial of RBP-6300
20 Apr 2016 02:00 PM
RNS
Notice of Results
15 Apr 2016 02:47 PM
RNS
Holding(s) in Company
08 Apr 2016 01:23 PM
RNS
Annual Financial Report
07 Apr 2016 02:30 PM
RNS
Directorate Change
11 Mar 2016 03:25 PM
RNS
Holding(s) in Company

Indivior is a pharmaceutical company that develops and sells treatments for addiction and other serious mental illnesses.

Founded in 1994 as a division of Reckitt Benckiser and demerged in 2014, Indivior is listed on the London Stock Exchange and the NASDAQ Global Select Market.

Indivior share price is listed in London under the ticker INDV.

UK 100